Diligent Investors, LLC Mesoblast LTD Transaction History

Diligent Investors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 10, 2024	SELL	$1.0 - $1.39 $1,500 - $2,085	-1,500 Reduced 12.0%	11,000 $12,000
Q3 2023 Nov 03, 2023	SELL	$1.22 - $4.83 $851 - $3,371	-698 Reduced 5.29%	12,500 $15,000
Q2 2021 Aug 12, 2021	BUY	$6.69 - $9.0 $3,345 - $4,500	500 Added 3.94%	13,198 $99,000
Q1 2021 Apr 23, 2021	BUY	$8.26 - $11.4 $8,260 - $11,400	1,000 Added 8.55%	12,698 $105,000
Q1 2020 Apr 29, 2020	BUY	$3.38 - $10.63 $169 - $531	50 Added 0.43%	11,698 $51,000
Q2 2019 Aug 01, 2019	SELL	$4.67 - $5.88 $3,026 - $3,810	-648 Reduced 5.27%	11,648 $62,000
Q2 2017 Aug 11, 2017	BUY	N/A	12,296	12,296 $98,000

151K

Ticker MESO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 147,316,000
Market Cap $1.2B
Description
Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...

Get notified when there are updates to the investment portfolio of Diligent Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Diligent Investors, LLC with notifications on news.